Journals 2022
Publications menu
        Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors.        
                  Archiv der Pharmazie.                
                  2022,
                
                              355(12),
                  
                              e2200419,
                          
                  ISSN: 0365-6233,
                
                
                              PMID: 36109178,                          
                
                          
        
      
    
        Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration.        
                  Biomedicine & Pharmacotherapy.                
                  2022,
                
                              154,
                  
                              113582,
                          
                  ISSN: 0753-3322,
                
                
                              PMID: 36055111,                          
                
                          
        
      
    
        The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression.        
                  Molecular Medicine Reports.                
                  2022,
                
                              26(4),
                  
                              321,
                          
                  ISSN: 1791-2997,
                
                
                              PMID: 36043519,                          
                
                          
        
      
    
        Influence of protein corona on the interaction of glycogen-siRNA constructs with ex vivo human blood immune cells.        
                  Biomaterials Advances.                
                  2022,
                
                              140,
                  
                              213083,
                          
                  ISSN: 2772-9508,
                
                
                              PMID: 36027666,                          
                
                          
        
      
    
        New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.        
                  Pharmaceutics.                
                  2022,
                
                              14(8),
                  
                              1712,
                          
                  ISSN: 1999-4923,
                
                
                              PMID: 36015338,